Paul V. Maier, Director at Eton Pharmaceuticals, Inc. (ETON), sold 50,000 shares at $58.64 ($3.0M) on 2026-08-28, disclosed to the SEC on 2026-08-28.
Open-market sale of $3.0M ETON by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.64 | 36,387 | $2.1M | 72.2% |
| 2 | $60.21 | 13,485 | $812K | 27.5% |
| 3 | $61.77 | 128 | $8K | 0.3% |
| Total | $59.07 avg | 50,000 | $3.0M | 100% |
| Filing → |
| MBVX | SELL | 2018-01-24 | $30K | — | Filing → |
| MBVX | BUY | 2015-06-02 | $12K | — | Filing → |
| SQNM | BUY | 2012-08-02 | $27K | — | Filing → |